Ledisa dopamine patches do not contain the chemical, a new class action alleges

Danielle Crisci filed a class action lawsuit against Ledisa LLC on Aug. 18, 2026, in the U.S. District Court for the District of New Jersey.

The complaint claims the wellness brand sells transdermal patches advertised as "dopamine patches" that contain no dopamine but rather a variety of herbal extracts, such as lion’s mane and rhodiola, which do not provide the same benefits as the actual dopamine chemical or a dopamine agonist.

Ledisa's alleged product and marketing claims

Ledisa began selling its adhesive dopamine patches in 2025 through its website and platforms like Amazon. The front of the pouch reportedly shows the product name in large type above the phrase "science-backed formula."

Online, a banner under the product listing calls the product the world's first dopamine support patch and promises better mood, more energy and a clearer mind, according to the proposed class action. Other marketing cited in the filing promises the product provides complete dopamine support and an end to afternoon crashes.

Taken together, the product's packaging and marketing lead a reasonable shopper to believe it delivers dopamine through the skin, the complaint claims. However, the lawsuit alleges this is not the case. The ingredients lists does not contain dopamine but rather macuna pruiens, 5-HTP, lion’s mane extract, l- tyrosine, rhodiola extract, and vitamin b6, which the proposed class action claims are not as effective as dopamine.

Who did Ledisa allegedly target?

Roughly 59% of U.S. adults worry about affording prescriptions and about 43% have not taken medication as prescribed because of cost, the complaint claims, citing March 2026 polling from KFF. Those costs push shoppers toward over-the-counter products promising drug-like results, and Ledisa positioned its patches for that group, the lawsuit alleges.

Crisci says she bought the patches around Jan. 1, 2026, on Ledisa's website after reading the dopamine claims. She claims she would not have purchased them if had she knew the product did not contain dopamine.

The legal claims

The lawsuit brings two counts:

  • New Jersey Consumer Fraud Act, a state law against deceptive practices in the sale of merchandise that requires courts to triple actual damages for prevailing plaintiffs and allows attorneys' fees
  • Unjust enrichment, a theory that applies when a company keeps payment for something materially different from what it advertised

Where the case stands for buyers

Crisci seeks actual damages, mandatory treble damages, disgorgement of Ledisa's profits, injunctive relief, interest, fees and costs. Ledisa has not yet answered the complaint. There is no settlement, claims process or payout at this stage.